At a glance
- Originator Chiron Corporation
- Class Antibacterials; Antituberculars; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Mycobacterium avium complex infections; Tuberculosis
Most Recent Events
- 04 Aug 1998 No-Development-Reported for Mycobacterium avium complex infections in USA (Unknown route)
- 04 Aug 1998 No-Development-Reported for Tuberculosis in USA (Unknown route)
- 18 Sep 1996 An in vitro study has been added to the antimicrobial activity section